Cas:773-37-5 1-(2-bromoethyl)adamantane manufacturer & supplier

Chemical Name:1-(2-bromoethyl)adamantane

CAS.NO:773-37-5

Synonyms:1-(adamantan-1-yl)-2-bromoethane;1-(2-Bromoethyl)adamantane;F1928-0018;2-adamantanyl-1-bromoethane;2-(adamant-1-yl)ethyl bromide;Tricyclo[3.3.1.1]decane, 1-(2-bromoethyl)-;2-(1-adamantyl)ethyl bromide;1-bromo-2-(adamant-1-yl)ethane;1-(2′-bromoethyl)adamantane

Molecular Formula:C₁₂H₁₉Br

Molecular Weight:243.183

HS Code:2903890090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:246.4±8.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.553

PSA:

Exact Mass:242.067001

LogP:5.09

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(adamantan-1-yl)-2-bromoethane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2′-bromoethyl)adamantane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(adamant-1-yl)ethyl bromide Use and application,1-(adamantan-1-yl)-2-bromoethane technical grade,usp/ep/jp grade.

Related News: In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape. 1-(2-bromoethyl)adamantane manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 1-(2-bromoethyl)adamantane supplier The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 1-(2-bromoethyl)adamantane vendor In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape. 1-(2-bromoethyl)adamantane factory The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful.